Hong Kong's No.2 Beauty & Healthcare Retailer! Lung Fung Group Passes HKEX Listing Hearing
New Timespace News: Lung Fung Group Holdings Limited passed its HKEX listing hearing on May 17, 2026, with DBS Group as the sole sponsor.
The company is a Hong Kong-based leading chain retailer of beauty products, healthcare products and pharmaceutical products. According to Frost & Sullivan, by retail sales value in 2024, the Group ranked second among beauty, healthcare and pharmaceutical retailers in Hong Kong with a 5.8% market share; by retail sales value, the company is the largest pharmaceutical retailer in Hong Kong with a 5.2% market share; by revenue, it is also the second largest pharmaceutical and healthcare retailer in Hong Kong with approximately 4.2% market share.
As of the latest practicable date, the company operates 31 retail stores under the "Lung Fung" brand in Hong Kong and various online sales platforms, offering customers a wide variety of value-for-money products. Its flagship store in Mong Kok's Grand Plaza provides a spacious and comfortable shopping environment with a gross floor area of approximately 17,500 square feet.
The company offers a wide range of beauty products, healthcare products, pharmaceutical products and other consumer products, including household daily necessities and food, covering 11 major categories: Chinese proprietary medicines, Western medicines, health supplements, skincare products, cosmetics, perfumes, personal care products, mother and baby products, food, pet food and household daily necessities.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
